DXN Holdings Bhd. (KLSE:DXN)

Malaysia · Delayed Price · Currency is MYR

0.4700

+0.0050 (1.08%)

At close: Aug 10, 2026

-6.93% (1Y)

Market Cap	2.32B -7.4%
Revenue (ttm)	1.89B -2.5%
Net Income	256.14M -19.1%
EPS	0.05 -19.1%
Shares Out	4.95B
PE Ratio	9.12
Forward PE	8.03
Dividend	0.03 (6.81%)
Ex-Dividend Date	Aug 12, 2026

Volume	3,405,600
Open	0.4650
Previous Close	0.4650
Day's Range	0.4650 - 0.4700
52-Week Range	0.4250 - 0.5500
Beta	0.20
Analysts	Buy
Price Target	0.57 (+21.28%)
Earnings Date	Oct 23, 2026

About DXN Holdings Bhd.

DXN Holdings Bhd. provides health food supplements in Malaysia, Asia, Latin America, the Middle East, Europe, Africa, Oceania, and North America. It operates through Health and Wellness Consumer Products; Investment Holding; and Other Non-Reportable segments. The company offers fortified food and beverages, health and dietary supplements, personal care products, and skin care and cosmetics, as well as management services. It also engages in the formulation of medicines; commercial lab testing; research, development, and experimental work on bio... [Read more]

Industry Pharmaceutical Preparations

Founded 1993

Employees 3,805

Stock Exchange Bursa Malaysia

Ticker Symbol DXN

Full Company Profile

Financial Performance

In fiscal year 2026, DXN Holdings Bhd.'s revenue was 1.93 billion, a decrease of -0.30% compared to the previous year's 1.94 billion. Earnings were 271.52 million, a decrease of -17.24%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for DXN stock is "Buy." The 12-month stock price target is RM 0.57, which is an increase of 21.28% from the latest price.

Price Target

RM 0.57

(21.28% upside)

Analyst Consensus: Buy

Stock Forecasts